Improvement in pulmonary function following antibiotics in infants with cystic fibrosis

Pediatric Pulmonology

Volumn 47, Issue 5, 2012, Pages 441-446

  Pittman, Jessica E ^a   Johnson, Robin C ^a   Davis, Stephanie D ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Cystic fibrosis; Infant; Pulmonary cystic fibrosis; Respiratory function tests

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PULMONARY VASCULAR OBSTRUCTIVE DISEASE; SCORING SYSTEM; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; LUNG; MALE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES;

EID: 84859823106     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21575     Document Type: Article

References (22)

1. Davis SD, Fordham LA, Brody AS, Noah TL, Retsch-Bogart GZ, Qaqish BF, Yankaskas BC, Johnson RC, Leigh MW. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007;175:943-950. (Pubitemid 46684705)
2. Stick SM, Brennan S, Murray C, Douglas T, von Ungern-Sternberg BS, Garratt LW, Gangell CL, De Klerk N, Linnane B, Ranganathan S, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009;155:623-628 e621.
3. Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 2005;40:500-510. (Pubitemid 41720706)
4. Kozlowska WJ, Bush A, Wade A, Aurora P, Carr SB, Castle RA, Hoo AF, Lum S, Price J, Ranganathan S, et al. Lung Function from infancy to the preschool years following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008;178: 42-49. (Pubitemid 351919192)
5. Ranganathan SC, Dezateux C, Bush A, Carr SB, Castle RA, Madge S, Price J, Stroobant J, Wade A, Wallis C, et al. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001;358:1964-1965. (Pubitemid 34072881)
6. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, Robertson CF, Robinson PJ, Franklin PJ, Turner SW, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008;178:1238-1244.
7. Davis PB. Pulmonary Disease in Cystic Fibrosis. In: Chernick V, Boat TF, Wilmott RW, Bush A, editors. Kendig's Disorders of the Respiratory Tract in Children. Philadelphia: Saunders Elsevier; 2006. p 873-886.
8. Davis PB. The decline and fall of pulmonary function in cystic fibrosis: new models, new lessons. J Pediatr 1997;131:789-790. (Pubitemid 28027596)
9. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000;161:353-359. (Pubitemid 30129438)
10. Lum S, Stocks J, Castile R, Davis S, Henschen M, Jones M, Morris MG, Ranganathan S, Sly PD, Tepper R. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005;172:1463-1471.
11. Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adulttype pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol 2000;30:215-227.
12. Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on standards for infant respiratory function testing. European Respiratory Society/American Thoracic Society. Eur Respir J 2001;17:302-312.
13. Davis SD, Brody AS, Emond MJ, Brumback LC, Rosenfeld M. Endpoints for clinical trials in young children with cystic fibrosis. Proc Am Thorac Soc 2007;4:418-430. (Pubitemid 47333916)
14. Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010; 182:1387-1397.
15. Loland L, Bisgaard H. Feasibility of repetitive lung function measurements by raised volume rapid thoracoabdominal compression during methacholine challenge in young infants. Chest 2008;133:115-122.
16. Dellon EP, Donaldson SH, Johnson R, Davis SD. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol 2008;43:1100-1106.
17. Subbarao P, Balkovec S, Solomon M, Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol 2007;42:471-476. (Pubitemid 46700947)
18. Tepper RS, Eigen H, Stevens J, Angelicchio C, Kisling J, Ambrosius W, Heilman D. Lower respiratory illness in infants and young children with cystic fibrosis: evaluation of treatment with intravenous hydrocortisone. Pediatr Pulmonol 1997;24: 48-51. (Pubitemid 27332706)
19. Sheikh S, Flucke R, McCoy K, Castile R. Changes in lung function during treatment for pulmonary exacerbations in infants with cystic fibrosis. Pediatric Pulmonol 2000;20: abstract 429 (pg. 296).
20. Clayton RG, Sr., Diaz CE, Bashir NS, Panitch HB, Schidlow DV, Allen JL. Pulmonary function in hospitalized infants and toddlers with cystic fibrosis. J Pediatr 1998;132:405-408. (Pubitemid 28180240)
21. Sanders DB, Bittner RC, Rosenfeld M, Hoffman LR, Redding GJ, Goss CH. Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation. Am J Respir Crit Care Med 2010;182:627-632.
22. Lum S, Hoo AF, Hulskamp G, Wade A, Stocks J. Potential misinterpretation of infant lung function unless prospective healthy controls are studied. Pediatr Pulmonol 2010;45:906-913.